News|Articles|February 21, 2024
Upstream Intensification – Enabling Perfusion Processes with Cell Retention Technologies
Author(s)Millipore Sigma
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
